DSGN vs PCG · $214.0M cap vs P/E 13, $37.68B cap
Design Therapeutics Inc (DSGN) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
PCG does not have a complete income-statement cache yet.
DSGN currently screens at market cap $214.0M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the DSGN and PCG stock pages for the full models.
Not investment advice.